Vertex Pharmaceuticals Inc.
[WKN: 882807 | ISIN: US92532F1003]
Aktienkurse
433,175€ 0,81%
Echtzeit-Aktienkurs Vertex Pharmaceuticals Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Vertex Pharmaceuticals: Coverage aufgenommen

Chicago (www.aktiencheck.de) - Rating-Update: Myles Minter, Analyst von William Blair & Co, nimmt die Coverage für die Aktie des Biotechkonzerns Vertex…

10 Analysts Have This to Say About Vertex Pharmaceuticals

Latest Ratings for VRTX DateFirmActionFromTo Feb 2022RBC CapitalDowngradesOutperformSector Perform Jan 2022BMO CapitalUpgradesMarket PerformOutperform Dec 2021Wells FargoInitiates Coverage OnOverweight …